- Home
- OBIO vs AUDC Comparison
OBIO vs AUDC Comparison
Compare OBIO & AUDC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | OBIO | AUDC |
|---|---|---|
| Founded | 2017 | 1992 |
| Country | United States | Israel |
| Employees | N/A | N/A |
| Industry | Medicinal Chemicals and Botanical Products | Telecommunications Equipment |
| Sector | Health Care | Utilities |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 237.2M | 267.0M |
| IPO Year | N/A | 1999 |
Fundamental Metrics
Financial Performance| Metric | OBIO | AUDC |
|---|---|---|
| Price | $4.19 | $8.85 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 5 | 3 |
| Target Price | ★ $14.00 | $11.67 |
| AVG Volume (30 Days) | ★ 202.4K | 92.1K |
| Earning Date | 11-10-2025 | 02-03-2026 |
| Dividend Yield | N/A | ★ 4.48% |
| EPS Growth | N/A | ★ 15.76 |
| EPS | N/A | ★ 0.46 |
| Revenue | $2,818,000.00 | ★ $244,553,000.00 |
| Revenue This Year | $35.75 | $2.98 |
| Revenue Next Year | $3.07 | $3.40 |
| P/E Ratio | ★ N/A | $19.19 |
| Revenue Growth | ★ 6.46 | 0.15 |
| 52 Week Low | $2.20 | $8.01 |
| 52 Week High | $6.30 | $12.72 |
Technical Indicators
Market Signals| Indicator | OBIO | AUDC |
|---|---|---|
| Relative Strength Index (RSI) | 44.27 | 46.09 |
| Support Level | $4.07 | $8.79 |
| Resistance Level | $4.37 | $8.96 |
| Average True Range (ATR) | 0.25 | 0.22 |
| MACD | -0.06 | 0.00 |
| Stochastic Oscillator | 16.80 | 12.52 |
Price Performance
Historical ComparisonAbout OBIO Orchestra BioMed Holdings Inc.
Orchestra BioMed Holdings Inc is a biomedical innovation company accelerating high-impact technologies to patients through risk-reward sharing partnerships. Its partnership-enabled business model focuses on forging strategic collaborations with medical device companies to drive the commercialization of the products it develops. The company's flagship product candidates include BackBeat Cardiac Neuromodulation Therapy (CNT) for the treatment of hypertension and Virtue Sirolimus AngioInfusionBalloon (SAB) for the treatment of atherosclerotic artery disease.
About AUDC AudioCodes Ltd.
AudioCodes Ltd develops and sells onverged voice over IP and data networking solutions, products and applications to service providers and channels, OEMs, network equipment providers and system integrators. Its products include IP phones, session border controllers, voice applications, multi-service business routers, digital and analog media gateways, among others. The company generates revenues from the sale of products through a direct sales force and sales representatives. Its geographic segments are Israel, Americas, Europe, and the Far East. It derives a majority of the revenues from Americas segment.